Literature DB >> 28893958

Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor-Dependent Repression of Claudin-2.

Leon Zheng1,2, Caleb J Kelly1,2, Kayla D Battista1,2, Rachel Schaefer1,2, Jordi M Lanis1,2, Erica E Alexeev1,2, Ruth X Wang1,2, Joseph C Onyiah1,2, Douglas J Kominsky3, Sean P Colgan4,2,5.   

Abstract

Commensal interactions between the enteric microbiota and distal intestine play important roles in regulating human health. Short-chain fatty acids (SCFAs), such as butyrate, produced through anaerobic microbial metabolism represent a major energy source for the host colonic epithelium and enhance epithelial barrier function through unclear mechanisms. Separate studies revealed that the epithelial anti-inflammatory IL-10 receptor α subunit (IL-10RA) is also important for barrier formation. Based on these findings, we examined if SCFAs promote epithelial barrier through IL-10RA-dependent mechanisms. Using human intestinal epithelial cells (IECs), we discovered that SCFAs, particularly butyrate, enhanced IEC barrier formation, induced IL-10RA mRNA, IL-10RA protein, and transactivation through activated Stat3 and HDAC inhibition. Loss and gain of IL-10RA expression directly correlates with IEC barrier formation and butyrate represses permeability-promoting claudin-2 tight-junction protein expression through an IL-10RA-dependent mechanism. Our findings provide a novel mechanism by which microbial-derived butyrate promotes barrier through IL-10RA-dependent repression of claudin-2.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28893958      PMCID: PMC5636678          DOI: 10.4049/jimmunol.1700105

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis.

Authors:  Louise E Glover; Brittelle E Bowers; Bejan Saeedi; Stefan F Ehrentraut; Eric L Campbell; Amanda J Bayless; Evgenia Dobrinskikh; Agnieszka A Kendrick; Caleb J Kelly; Adrianne Burgess; Lauren Miller; Douglas J Kominsky; Paul Jedlicka; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

Authors:  Nagendra Singh; Ashish Gurav; Sathish Sivaprakasam; Evan Brady; Ravi Padia; Huidong Shi; Muthusamy Thangaraju; Puttur D Prasad; Santhakumar Manicassamy; David H Munn; Jeffrey R Lee; Stefan Offermanns; Vadivel Ganapathy
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

4.  Regulation of TWIK-related potassium channel-1 (Trek1) restitutes intestinal epithelial barrier function.

Authors:  Huang Huang; Jiang-Qi Liu; Yong Yu; Li-Hua Mo; Rong-Ti Ge; Huan-Ping Zhang; Zhi-Gang Liu; Peng-Yuan Zheng; Ping-Chang Yang
Journal:  Cell Mol Immunol       Date:  2015-02-16       Impact factor: 11.530

5.  Lack of interleukin 10 regulation of antigen presentation-associated molecules expressed on colonic epithelial cells.

Authors:  A Bourreille; J P Segain; D Raingeard de la Blétière; S Siavoshian; G Vallette; J P Galmiche; H M Blottière
Journal:  Eur J Clin Invest       Date:  1999-01       Impact factor: 4.686

6.  Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.

Authors:  Caleb J Kelly; Leon Zheng; Eric L Campbell; Bejan Saeedi; Carsten C Scholz; Amanda J Bayless; Kelly E Wilson; Louise E Glover; Douglas J Kominsky; Aaron Magnuson; Tiffany L Weir; Stefan F Ehrentraut; Christina Pickel; Kristine A Kuhn; Jordi M Lanis; Vu Nguyen; Cormac T Taylor; Sean P Colgan
Journal:  Cell Host Microbe       Date:  2015-04-09       Impact factor: 21.023

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 8.  NF-kappaB in inflammatory bowel disease.

Authors:  I Atreya; R Atreya; M F Neurath
Journal:  J Intern Med       Date:  2008-06       Impact factor: 8.989

9.  Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.

Authors:  Marehalli L Nagalakshmi; Anne Rascle; Sandra Zurawski; Satish Menon; Rene de Waal Malefyt
Journal:  Int Immunopharmacol       Date:  2004-05       Impact factor: 4.932

10.  HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity.

Authors:  Bejan J Saeedi; Daniel J Kao; David A Kitzenberg; Evgenia Dobrinskikh; Kayla D Schwisow; Joanne C Masterson; Agnieszka A Kendrick; Caleb J Kelly; Amanda J Bayless; Douglas J Kominsky; Eric L Campbell; Kristine A Kuhn; Glenn T Furuta; Sean P Colgan; Louise E Glover
Journal:  Mol Biol Cell       Date:  2015-04-22       Impact factor: 4.138

View more
  97 in total

Review 1.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 2.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.

Authors:  Yasaman Ghorbani; Katherine J P Schwenger; Johane P Allard
Journal:  Eur J Nutr       Date:  2021-03-02       Impact factor: 5.614

Review 3.  Probiotics, Nutrition, and the Small Intestine.

Authors:  Taylor C Judkins; Douglas L Archer; Dean C Kramer; Rebecca J Solch
Journal:  Curr Gastroenterol Rep       Date:  2020-01-13

Review 4.  Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity.

Authors:  Amelia T Soderholm; Virginia A Pedicord
Journal:  Immunology       Date:  2019-10-04       Impact factor: 7.397

Review 5.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

6.  Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  SeonYoon Chung; Jennifer L Barnes; Kim Schafer Astroth
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

Review 7.  A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.

Authors:  Wangxin Liu; Xianliang Luo; Jun Tang; Qiufen Mo; Hao Zhong; Hui Zhang; Fengqin Feng
Journal:  Eur J Nutr       Date:  2020-11-12       Impact factor: 5.614

8.  Slug and Snail have differential effects in directing colonic epithelial wound healing and partially mediate the restitutive effects of butyrate.

Authors:  Steve D Swain; Heather N Grifka-Walk; Jeannie Gripentrog; Margaret Lehmann; Benjamin Deuling; Brittany Jenkins; Hailey Liss; Nathan Blaseg; Diane Bimczok; Douglas J Kominsky
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-08       Impact factor: 4.052

Review 9.  Immune regulation by microbiome metabolites.

Authors:  Chang H Kim
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

10.  Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness.

Authors:  Ratanesh Kumar Seth; Diana Kimono; Firas Alhasson; Sutapa Sarkar; Muayad Albadrani; Stephen K Lasley; Ronnie Horner; Patricia Janulewicz; Mitzi Nagarkatti; Prakash Nagarkatti; Kimberly Sullivan; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2018-05-09       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.